
News|Articles|September 3, 2026
SPECTRUM: Early Clinical Data and Practice Experience From Global Real-World Study of Intravitreal Aflibercept (EYLEA®, Bayer AG) 8mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Advertisement
SPECTRUM: Early Clinical Data and Practice Experience From Global Real-World Study of Intravitreal Aflibercept (EYLEA®, Bayer AG) 8mg in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Presentation highlights from the Association for Research in Vision and Ophthalmology (ARVO) 2026 annual meeting
Advertisement
Related Content
Advertisement

Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
The importance of treating EBMD before cataract surgery
3
How screen time and eyelid health affect dry eye risk
4
ESCRS 2026: Why surgeons should be willing to use what they prescribe to patients
5







